Total Synthesis and SAR Studies
Total Page:16
File Type:pdf, Size:1020Kb
Research Collection Doctoral Thesis Resorcylic lactone L-783277 as a new lead structure for kinase inhibition total synthesis and SAR studies Author(s): Hofmann, Tatjana Publication Date: 2009 Permanent Link: https://doi.org/10.3929/ethz-a-005826434 Rights / License: In Copyright - Non-Commercial Use Permitted This page was generated automatically upon download from the ETH Zurich Research Collection. For more information please consult the Terms of use. ETH Library Diss. ETH No. 18336 Resorcylic Lactone L-783277 as a New Lead Structure for Kinase Inhibition – Total Synthesis and SAR Studies A dissertation submitted to the Swiss Federal Institute of Technology Zurich For the degree of Doctor of Sciences ETH Zurich Presented by Tatjana Hofmann Dipl. Chem. Johann Wolfgang Goethe-Universität Frankfurt am Main Born March 29, 1978 Citizen of the Federal Republic of Germany Accepted on the recommendation of Prof. Dr. Karl-Heinz Altmann, examiner Prof. Dr. P. August Schubiger, co-examiner Zurich, 2009 Dedicated to my parents I am among those who think that science has great beauty. A scientist in his laboratory is not only a technician: he is also a child placed before natural phenomena which impress him like a fairy tale. Marie Curie (1867 - 1934) The great tragedy of Science – the slaying of a beautiful hypothesis by an ugly fact. Thomas H. Huxley (1825 - 1895) Acknowledgments First of all I would like to thank Prof. Karl-Heinz Altmann for giving me the opportunity to accomplish my PhD thesis in his research group. I had always the freedom to come up with my own ideas and suggestions and I did really appreciate his guidance, support and interest in my project. I am grateful to Prof. Pius August Schubiger for being the co-examiner of my thesis. Furthermore, he did not hesitate to support me when I kindly asked him to act as a referee for funding bodies. In addition I would like to thank Prof. Michael Detmar and Benjamin Vigl for our collaboration. My personal thanks go Silvia Anthoine Dietrich, Dr. Cotinica Hamel, Fabienne Zdenka Gaugaz, Didier Zurwerra and Dr. Evgeny Prusov. I was fortunate to work together with these highly skilled chemists and understanding as well as supporting characters. Thanks to all of them I enjoyed my time at the ETH and in Switzerland. Kurt Hauenstein is a patient, very helpful, hard-working and highly skilled technician. Thanks to him, I learned a lot of practical skills and I really appreciate that. During my PhD thesis I was responsible for the supervision of three undergraduate students during their “Semesterarbeit” as well as their diploma and master theses. Fabienne Zdenka Gaugaz is a highly talented and motivated student, who owns an indefatigable positive mind and charisma. I am really proud of her return to the group and that she started her own PhD thesis in 2008. Heike Kirchner stayed with me for her external diploma thesis and I appreciated her being a passionate and hardworking student, even if she had to overcome several synthesis problems. Luca Fransioli was my last student and he did a fantastic job. He almost finished two synthesis projects with his straightforward and painstaking working attitude. I wish him all the best for his future and I envy his new colleagues. I would also like to thank Dr. Pascal Furet (Novartis Institute for Biomedical Research, Basel) for modeling studies and Dr. Doriano Fabbro (Novartis Institute for Biomedical Research, Basel) for the biological evaluation of my compounds. I am grateful to Novartis for a one year Doctoral Fellowship in 2006. Special thanks go to the Altmann research group. We have always had an enjoyable and fruitful working atmosphere. In conclusion, I would like to thank Nicola Feyen for her patience while teaching me English and Tobias Ross, Simone Jeger, Martina Adams, Annette Rincker, Nadine Neumann, my sister Stephanie, my dad and Karin for their emotional support. Curriculum Vitae Personal Details Name Tatjana Hofmann Date of birth 29th March 1978 Place of birth Fulda, Germany Nationality German Employment 2005-present PhD student in the group of Prof. Dr. Karl-Heinz Altmann, Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences (D-CHAB), ETH Zürich, Switzerland “Resorcylic Lactone L-783277 as a New Lead Structure for Kinase Inhibition - Total Synthesis and SAR Studies“ Supervision of Masters students and leading practical courses for undergraduate students Responsible for NMR service and maintenance 2004-2004 Diploma student in the group of Prof. Dr. Engels, Department of Organic Chemistry and Chemical Biology (OCCB), Johann Wolfgang Goethe University, Frankfurt am Main, Germany “Synthesis of Minor Groove Labelled 2’-Deoxyguanosines” Education 2000-2004 Johann Wolfgang Goethe University, Frankfurt am Main, Germany Graduated with diploma in chemistry (equivalent to Masters Degree) - Grade awarded equivalent to first class honors 1st state examination in botany 1997-2000 Provadis GmbH, Industrie Park Höchst, Frankfurt am Main, Germany Vocational training as laboratory assistant (qualification awarded by German Chamber of Commerce and Industry) 1988-1997 Albert - Einstein Schule, Gymnasium in Schwalbach am Taunus, Germany “Abitur“ (equivalent to A levels) Awards 2006-2007 Novartis Doctoral Fellowship for 2006 Work Experience 11-12/2004 Novartis Pharma AG, Basel, Switzerland Synthesis of low-molecular weight kinase inhibitors 02-03/2000 Aventis Pharma Deutschland AG, Frankfurt am Main, Germany Metabolism and Arthritis: lead optimisation of relevant candidates Publications Tatjana Hofmann, Karl-Heinz Altmann Resorcylic Acid Lactones as New Lead Structures for Kinase Inhibition Comptes Rendus Chimie 2008, 11, 1318-1335 Tatjana Hofmann, Karl-Heinz Altmann Total Synthesis of the Resorcylic Lactone-Based Kinase Inhibitor L-783277 Synlett 2008, 10, 1500-1504 Tatjana Hofmann, Karin Zweig; Joachim W. Engels A New Synthetic Approach for the Synthesis of N2-Modified Guanosines Synthesis 2005, 11, 1797-1800 Oral Presentations Tatjana Hofmann, Karl-Heinz Altmann Resorcylic Lactone L-783277 as a New Lead Structure for Kinase Inhibition - Total Synthesis and SAR Studies Frontiers in Medicinal Chemistry 2009, Heidelberg, Germany 2009 Tatjana Hofmann, Karl-Heinz Altmann Total Synthesis of the Resorcylic Lactone-based Kinase Inhibitor L-783277 Fall Session 2008, Swiss Chemical Society Meeting 2008; Zurich, Switzerland 2008 Tatjana Hofmann, Karl-Heinz Altmann Studies on the Total Synthesis of Resorcylic Lactone L-783277 - A New Lead Structure for Kinase Inhibition Doktorandentag - Fall Session 2007, ETH Zürich, Switzerland 2007 Poster Presentations Tatjana Hofmann, Karl-Heinz Altmann Studies on the Total Synthesis of Resorcylic Lactone L-783277 - A New Lead Structure for Kinase Inhibition Swiss Chemical Society Meeting 2007; Lausanne, Switzerland 2007 Hofmann, Tatjana; Karl-Heinz Altmann Resorcylic Lactone L-783277 as a New Lead Structure for Kinase Inhibition - Total Synthesis and SAR Studies Frontiers in Medicinal Chemistry 2007, Berlin, Germany 2007 Table of Contents Abstract...................................................................................................................... I Zusammenfassung.................................................................................................. IV List of Abbreviations, Acronyms and Symbols ................................................... VII 1. Introduction ....................................................................................................... 1 1.1. Resorcylic Acid Lactones (RALs) ................................................................. 1 1.1.1. Biosynthesis of RALs........................................................................................2 1.1.2. Biological Activity of RALs ................................................................................2 1.2. MAP Kinase Pathways ................................................................................. 5 1.3. Clinically Approved Kinase Inhibitors ........................................................... 7 1.4. Total Syntheses of Cis-Enone Containing RALs ........................................ 11 1.4.1. LL-Z1640-2 and Hypothemycin ......................................................................11 1.4.2. Radicicol A......................................................................................................20 1.4.3. Aigialomycin D ................................................................................................23 1.5. Conclusions................................................................................................ 34 2. Aims and Scope .............................................................................................. 35 2.1. Retrosynthetic Analysis of L-783277 .......................................................... 35 2.1.1. First Generation Approach..............................................................................35 2.1.2. Second Generation Approach ........................................................................37 2.1.3. Still-Gennari Approach....................................................................................38 2.2. Retrosynthetic Analysis of the Dideoxy Analog D6..................................... 40 2.3. Retrosynthetic Analysis of the Phenyl Analog P6....................................... 40 2.3.1. Alkyne Metathesis Approach ..........................................................................41 2.3.2. Macrolactonization Approach .........................................................................42